Though not accurate enough to be used alone, autoantibodies to p53 showed consistently promising results as a marker for early diagnosis of colorectal cancer and might serve as a supplement to methylated Septin 9 testing or in a future multi-marker panel. The gene discussed is TP53; the disease is colorectal cancer.